Skip to content

Homocysteine and Atherothrombosis

George N. Welch, Joseph Loscalzo

New England Journal of Medicine · 1998 · 1,998 citations

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Welch, G. N., & Loscalzo, J. (1998). Homocysteine and atherothrombosis. New England Journal of Medicine, 338(15), 1042–1050. https://doi.org/10.1056/nejm199804093381507

In text: (Welch & Loscalzo, 1998)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

In 1969, McCully made the clinical observation linking elevated plasma homocyst(e)ine concentrations with vascular disease.1 He reported autopsy evidence of extensive arterial thrombosis and atherosclerosis in two children with elevated plasma homocyst(e)ine concentrations and homocystinuria. On the basis of this observation, he proposed that elevated plasma homocyst(e)ine (hyperhomocyst(e)inemia) can cause atherosclerotic vascular disease. The term “homocyst(e)ine” is used to define the combined pool of homocysteine, homocystine, mixed disulfides involving homocysteine, and homocysteine thiolactone found in the plasma of patients with hyperhomocyst(e)inemia.Subsequent investigations have confirmed McCully's hypothesis, and it has recently become clear that hyperhomocyst(e)inemia is an independent risk factor . . .

  1. A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease1995
  2. Tietz Textbook of Clinical Chemistry1999
  3. Homocysteine and Cardiovascular Disease1998
  4. Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease1991
  5. Homocysteine and Risk of Ischemic Heart Disease and Stroke2002

Metadata from OpenAlex (CC0). Citations are generated from the published record.